LAZZARINI, GIORGIA
LAZZARINI, GIORGIA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Assegnisti
Distinct proteomic profiles characterise non-erosive from erosive reflux disease.
2011 Calabrese C; Marzano V; Urbani A; Lazzarini G; Valerii MC; Liguori G; Di Molfetta S; Rizzello F; Gionchetti P; Campieri M; Spisni E.
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon
2013 Valerii M.C.; Benaglia M.; Caggiano C.; Papi A.; Strillacci A.; Lazzarini G.; Campieri M.; Gionchetti P.; Rizzello F.; Spisni E.
MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells.
2009 Strillacci A; Griffoni C; Sansone P; Paterini P; Piazzi G; Lazzarini G; Spisni E; Pantaleo MA; Biasco G; Tomasi V.
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease
2010 Calabrese C; Spisni E; Liguori G; Lazzarini G; Valerii MC; Strillacci A; Gionchetti P; Pagotto U; Campieri M; Rizzello F.
RNAi-based strategies for cyclooxygenase-2 inhibition in cancer.
2010 Strillacci Antonio; Griffoni Cristiana; Valerii Maria Chiara; Lazzarini Giorgia; Tomasi Vittorio; Spisni Enzo
Selective cyclooxygenase-2 (COX-2) silencing mediated by engineered Escherichia coli and RNA Interference induces anti-tumour effects in human colon cancer cells
2010 A. Strillacci; C. Griffoni; G. Lazzarini; M. C. Valerii; S. Di Molfetta; F.Rizzello; M. Campieri; M. P. Moyer; V. Tomasi; E. Spisni
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Distinct proteomic profiles characterise non-erosive from erosive reflux disease. | Calabrese C; Marzano V; Urbani A; Lazzarini G; Valerii MC; Liguori G; Di Molfetta S; Rizzello F; ...Gionchetti P; Campieri M; Spisni E. | 2011-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon | Valerii M.C.; Benaglia M.; Caggiano C.; Papi A.; Strillacci A.; Lazzarini G.; Campieri M.; Gionch...etti P.; Rizzello F.; Spisni E. | 2013-01-01 | NANOMEDICINE | - | 1.01 Articolo in rivista | - |
| MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. | Strillacci A; Griffoni C; Sansone P; Paterini P; Piazzi G; Lazzarini G; Spisni E; Pantaleo MA; Bi...asco G; Tomasi V. | 2009-01-01 | EXPERIMENTAL CELL RESEARCH | - | 1.01 Articolo in rivista | - |
| Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease | Calabrese C; Spisni E; Liguori G; Lazzarini G; Valerii MC; Strillacci A; Gionchetti P; Pagotto U;... Campieri M; Rizzello F. | 2010-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| RNAi-based strategies for cyclooxygenase-2 inhibition in cancer. | Strillacci Antonio; Griffoni Cristiana; Valerii Maria Chiara; Lazzarini Giorgia; Tomasi Vittorio;... Spisni Enzo | 2010-01-01 | JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY | - | 1.01 Articolo in rivista | - |
| Selective cyclooxygenase-2 (COX-2) silencing mediated by engineered Escherichia coli and RNA Interference induces anti-tumour effects in human colon cancer cells | A. Strillacci; C. Griffoni; G. Lazzarini; M. C. Valerii; S. Di Molfetta; F.Rizzello; M. Campieri;... M. P. Moyer; V. Tomasi; E. Spisni | 2010-01-01 | BRITISH JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |